Researchers from the University of Pennsylvania’s Abramson Cancer Center presented preliminary results of an ongoing Phase I clinical trial demonstrating successful re-treatment with CAR T cell therapy for patients whose cancers relapsed after previous CAR T therapy at the 2022 American Society of Hematology (ASH) Annual Meeting (Abstract 2016).
Researchers from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania will be presenting data on the latest advances in blood cancer research and treatment at the 2022 American Society of Hematology (ASH) Annual Meeting from December 10-13.
This special edition features presentations by MD Anderson researchers at the 2022 American Society of Hematology (ASH) Annual Meeting on innovative targeted therapies, new combination approaches and novel targets to improve outcomes for patients with leukemias, Hodgkin lymphoma, non-Hodgkin lymphoma, myeloma and other hematologic cancers.
Scientists showed that nucleolar protein nucleophosmin ( NPM1), the defection of which can cause the development of leukemia and other types of cancer, deals with its regulatory protein only by phosphorylation of nucleophosmin (including “phosphate marker” in its composition).
Study is one of the first to associate long COVID symptoms with changes in gene expression during acute COVID-19
Physician-scientists from Cedars-Sinai Cancer will present research and are available for comment on breaking news throughout the American Society of Hematology Annual Meeting & Exposition taking place Dec. 10-13 in New Orleans.
Christopher Flowers, M.D., division head ad interim of Cancer Medicine and chair of Lymphoma & Myeloma at The University of Texas MD Anderson Cancer Center, has received a 2022 ASH Mentor Award from the American Society of Hematology in acknowledgement of his career-long commitment to mentoring.
Blood donations typically dwindle in the winter months, and are needed for cancer patients. Blood and Marrow Transplant Coordinator at Rutgers Cancer Institute of New Jersey shares what everyone should know about donating blood.
Chronic venous insufficiency (CVI) is a vascular condition affecting millions of people in the United States in which veins in the leg cannot efficiently carry blood back to the heart for oxygenation. For patients suffering from the condition, malfunctioning valves can cause blood to flow backwards and pool in the veins in the legs, which can lead to significant downstream affects for some people.
In APL Bioengineering, researchers examine the local communication between endothelial cells and tumors cells and its effects on endothelial cell orientation. The approach uses co-cultured human umbilical vein endothelial cells and breast epithelial tumor cell lines to simulate the tumor-endothelial interaction. The group found the clockwise chirality of the hUVECs was less affected by local hormone signaling and more so by direct physical contact with tumor cells. Specific proteins on the tumor cell binding to others on endothelial cells appeared to play a role in changing the clockwise chirality of hUVECs.
Researchers can detect small "toxic" aggregates of a particular protein in the blood of individuals with Alzheimer's disease and in individuals who showed no signs of cognitive impairment at the time the blood sample was taken, but who developed it at a later date.
SEATTLE — Dec. 1, 2022 — The 64th Annual Meeting and Exposition of the American Society of Hematology (ASH) will take place virtually and in person Dec. 10-13 in New Orleans, Louisiana.
A new study have identified which blood tests are best at detecting Alzheimer’s disease during the earliest stages, and another blood test that is optimal for detecting relevant treatment effects.
Physician-scientist Fanny Elahi, MD, PhD, to lead research team in collaboration with non-profit organization
Several national media outlets are reporting that the FDA is considering a new strategy for screening gay and bisexual men to help combat the national blood shortage. Florida State University’s nationally recognized experts are available to provide context to reporters who are working on this story as it develops.
A team of Lawrence Livermore National Laboratory (LLNL) scientists has developed a new technique to analyze fentanyl in human blood and urine samples that could aid work in the fields of medicine and chemical forensics.
A roundup of the latest research discoveries and faculty news at Cedars-Sinai.
A pilot, “look-back” study of information about 106 patients with “wet” age-related macular degeneration (AMD) treated at the Wilmer Eye Institute at Johns Hopkins Medicine has revealed that nearly half of patients treated with aflibercept could safely stop eye injection therapy after one year without further vision loss.
Measuring the amount of DNA that’s been shed by a tumor compared to the body’s typical amount of DNA may be a new tool to predict survival and guide treatment discussions for patients whose cancer has spread from the breast, prostate, lung or colon, a new study finds.
NIBIB-funded researchers are fine-tuning a wearable, cuffless blood pressure monitor. Made of graphene, one of the thinnest materials in the world, the device is worn on the underside of the wrist and can measure blood pressure with comparable accuracy to a standard blood pressure cuff.
November is Caregiver Awareness Month, and timely findings from a study published in Blood Advances suggest that, among caregivers of patients undergoing a stem cell transplant, how someone approaches coping can influence their levels of anxiety, depression, and poor quality of life (QOL) they experience.
A novel artificial intelligence blood testing technology developed and used by Johns Hopkins Kimmel Cancer Center researchers to successfully detect lung cancer in a 2021 study has now detected more than 80% of liver cancers in a new study of 724 people.
Researchers at Karolinska Institutet in Sweden have shown that patients with acute COVID-19 infection have increased levels of the cytokine IL-26 in their blood.
Daniel Herranz Benito, PharmD, PhD, resident researcher at Rutgers Cancer Institute of New Jersey, has received a five-year, $600,000 award from the Leukemia and Lymphoma Society (LLS) to support ongoing research efforts in T-cell acute lymphoblastic leukemia (T-ALL).
A small group of brain cells linked in a circuit is responsible for setting off whole-brain seizures in a rare form of epilepsy affected by blood sugar levels, a study led by UT Southwestern researchers suggests. The finding, published in Science Translational Medicine, could lead to new treatments for other metabolic disorders in the brain, the authors said.
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts. Current advances include a promising targeted therapy combination for patients with relapsed/refractory acute myeloid leukemia (AML), a link between the gut microbiome and therapy-related neutropenic fever, a novel therapeutic target for immunotherapy-related colitis, a telementoring model for training providers on cervical cancer prevention in limited-resource areas, a new understanding of the prognostic value of RUNX1 mutations in AML, and insights into the effects of opioid use on the pain sensitivity pathway.
The National Institutes of Health has awarded Albert Einstein College of Medicine a five-year, $6.6 million grant to lead a New York-based consortium of medical schools to train young scientists in kidney, urology, and hematology research.
Researchers from the University of Missouri School of Medicine have discovered how obstructive sleep apnea (OSA) changes the profiles of immune cells in the blood, leading to a unique cellular signature that can accurately detect obstructive sleep apnea in children.
The recovery of Jesus Torres, a patient at Loyola Medicine with acute myeloid leukemia, highlights the importance of access to innovative, experimental treatments for blood cancers for all communities. As a world-class research institute, Loyola Medicine provides unique, life-saving therapies through its participation in clinical trials, such as a phase 3 clinical trial that uses umbilical cord blood transplantation to treat patients with acute myeloid leukemia.
Scientists from Oxford University and the University of Birmingham have made the first bone marrow ‘organoids’ that capture the key features of human bone marrow.
Did you ever think of jellyfish or a salamander as fluorescent? That is actually the case. Both animals have proteins in their bodies that enables them to light up.
Hosted by Chulalongkorn University the APRU APEC University Leaders' Forum 2022 is the first post-pandemic in-person APEC meeting held to foster high-level dialogue between CEOs, policy leaders, university presidents, and top researchers. This event begins Nov 15 at 9 PM EST.
The advent of cell phones, the internet, and various messaging platforms has allowed for faster and broader communication worldwide.
Scientists have used a proteomics approach to identify a three-protein signature in the blood that can improve detection of isolated impaired glucose tolerance, a form of prediabetes.
In a study of pregnant women in the United States, Cedars-Sinai investigators found that a specific imbalance of two placental proteins could predict which women were at risk of developing a severe form of preeclampsia, a life-threatening blood pressure disorder.
Here are some of the latest articles that have been added to the Arthritis channel on Newswise.
De acuerdo a un nuevo análisis dirigido por investigadores de Cedars-Sinai y llevado a cabo en tres grandes sistemas de salud, el control y manejo de la hipertensión empeoraron durante los primeros meses de la pandemia de COVID-19.
Pioneering research into the chronic inflammation often seen in certain blood cancers has identified a promising treatment approach for myelofibrosis, a potentially deadly bone marrow cancer.
New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found that adult RA patients starting opioids had twice the risk of venous thromboembolism (VTE) compared to patients starting nonsteroidal anti-inflammatory drugs (NSAIDs).
New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, demonstrated an association between age of diagnosis and clinical characteristics and treatments in Anti-neutrophil cytoplasmic antibody-associated vasculitis patients.
Researchers have discovered the vital role of a hormone, that develops in men during puberty, in providing an early prediction of whether they could develop certain diseases in later life.
estoring blood flow to the legs, whether through bypass surgery or a less invasive artery-opening procedure with a stent, reduced pain and improved quality of life for people with peripheral artery disease (PAD), according to preliminary, late-breaking research presented today at the American Heart Association’s Scientific Sessions 2022.
A former fellow at the UNM Comprehensive Cancer Center, Dr. Shashank Cingam comes back to New Mexico to Treat blood cancers.
Multicentric Castleman disease (MCD) comprises a heterogenous group of rare disorders that exhibit generalized symptoms such as swelling of lymph nodes, anemia, fever, and fatigue.
Mount Sinai and Memorial Sloan Kettering Cancer Center (MSK) researchers have identified therapies that can help patients with the blood cancer multiple myeloma who try an immunotherapy known as CAR-T only to find their cancer coming back afterwards.
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts.
A targeted therapy for children with high-risk Hodgkin lymphoma significantly reduced relapse rates, a large multicenter clinical trial conducted by the Children’s Oncology Group shows. The study results have been reported in the New England Journal of Medicine.
The Flow Cytometry Core at Sanford Burnham Prebys is getting a new piece of state-of-the-art research equipment, thanks to a grant from the National Institutes of Health.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
